TNF Pharmaceuticals, Inc. (TNFA)
NASDAQ: TNFA · Real-Time Price · USD
0.479
-0.013 (-2.62%)
At close: Feb 21, 2025, 4:00 PM
0.500
+0.021 (4.36%)
After-hours: Feb 21, 2025, 7:57 PM EST
TNF Pharmaceuticals Employees
TNF Pharmaceuticals had 6 employees as of December 31, 2023. The number of employees decreased by 3 or -33.33% compared to the previous year.
Employees
6
Change (1Y)
-3
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$4,819,489
Market Cap
1.32M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6 | -3 | -33.33% |
Dec 31, 2022 | 9 | 0 | - |
Dec 31, 2021 | 9 | 3 | 50.00% |
Dec 31, 2020 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
TNFA News
- 24 days ago - TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment - Business Wire
- 5 weeks ago - TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion - Business Wire
- 2 months ago - TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs - Business Wire
- 2 months ago - TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference - Business Wire
- 5 months ago - TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market - Business Wire
- 6 months ago - TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline - Business Wire
- 7 months ago - TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today - Business Wire
- 7 months ago - MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc. - Business Wire